Search is Powered by Google
Cancer / Oncology News

Grants Awarded For Cancer Screening Intervention, Diabetes Programs

Main Category: Cancer / Oncology
Also Included In: Diabetes
Article Date: 14 Jan 2008 - 6:00 PST

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article


Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

American Cancer Society: The group on Thursday awarded Kevin Fiscella, a University of Rochester researcher, a $1.06 million grant to boost the number of minority and uninsured individuals who receive screenings for breast and colon cancers. Under the four-year program, Fiscella will create a registry of patients who visit federally funded health centers in the Rochester area. He also will establish intervention strategies, including letters, phone calls and home visits, to follow up with people who have not received screenings. Fiscella intends to launch a pilot of the project in which doctors and outreach workers will test which messages and interventions work best (Wang, Rochester Democrat and Chronicle, 1/11).

  • El Rio Community Health Center: The Bank of America Charitable Trust Foundation has given the community center $250,000 for the Pharmacy-Based Diabetes Program, which provides one-on-one counseling and diabetes management to a patient population mostly made up of minorities. Through the program, patients with diabetes are placed on regimens specifically designed for them. The money will cover a new, part-time prescribing pharmacist, which will help the program serve 200 additional patients (McClain, Arizona Daily Star, 1/8).

  • St. John's Regional Medical Center: Rep. Lois Capps (D-Calif.) said in a meeting with hospital President T. Michael Murray, physicians, policymakers and local residents that the hospital's Latino Healthcare League diabetes initiative will receive $390,000 in federal funds. John Cortes -- director of education, health ministries and healthy beginnings at the hospital -- said the funding will go toward hosting a diabetes academy to teach physicians about diagnosing and advising patients who are prediabetic or have diabetes. The funding also will be used for youth outreach, including advertisements, fliers and school programs (Guzik, VC Reporter, 1/10).


  • Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation© 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.




    Personalized Homepage Weekly Newsletters Daily News Alerts
    Opioid Induced Constipation ADHD Anxiety Asthma Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles All 'How To...' Articles

    Ophthalmology Urology
    About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

    add medical news today to your facebook
    medical news gadget

    Swine Flu Image

    Swine Flu Updates

    - Latest Swine Flu News
    - What is Swine Flu?
    - Map Of H1N1 Outbreaks
    - Swine Flu - Top 20 FAQ
    - Daily Email News Alerts
    Stick with Medical News Today for the latest news updates on swine flu.


    These are the most read articles from this news category for the last 6 months:
    Top Article Star
    Understanding And Treating Triple-Negative Breast Cancer
    07 Jan 2009
    Triple-negative breast cancer is a subtype of breast cancer that is clinically negative for expression of estrogen and progesterone receptors (ER/PR) and HER2 protein. It is characterized by its unique molecular profile...


    Monitoring and Adherence in CML image Monitoring and Adherence in CML

    Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

    Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

    There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

    View more videos...